Imre Noth, MD

University of ChicagoChicago, Illinois - 60637 |
- CLINICAL TRIALS 5
- CONDITIONS5
- INTERVENTIONS6
- SINCE2005

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
December 2009 - August 2011

Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis
September 2010 - September 2011

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
October 2009 - December 2011

A Study of the Natural Progression of Interstitial Lung Disease (ILD)
September 2005 - December 2013

Evaluating the Effectiveness of Prednisone Azathioprine and N-acetylcysteine in People With Idiopathic Pulmonary Fibrosis
October 2009 - December 2011
Lung Diseases
Fibrosis
Sarcoidosis
Pulmonary Fibrosis
Lung Diseases, Interstitial
Placebo
Azathioprine
Prednisone
Warfarin
Iw001
N-Acetylcysteine (Nac)



